MMN as a translational biomarker of psychosis: from bench-to-bedside-to-real-world community settings

Thursday, Sep 10, 2015
9:30-10:30
Hörsaal 3

Chair

Juanita Todd and Gregory Light

Contributions

• MMN as a highly sensitive measure of subtle changes in NMDAR-mediated glutamate transmission in mice
  Steven Siegel
• Structural and functional brain correlates of at-risk mental state
  Ulrich Schall
• MMN, cortisol, inflammation, and gray matter loss in individuals at clinical high risk for psychosis
  Daniel Mathalon
• The “Other Side” of translational biomarker development: taking MMN out of academic labs and into real-world settings to improve our understanding and treatment of psychosis
  Gregory A. Light